Last reviewed · How we verify
NCT04659577
Attitudes of Professionals and the General Public in Israel Regarding ICBT
NA trial testing ICBT for panic and depression in Panic Disorder in 130 participants. Completed in 31 January 2022.
31 August 2021
Quick facts
| Lead sponsor | Hebrew University of Jerusalem |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 130 |
| Start date | 1 November 2016 |
| Primary completion | 31 August 2021 |
| Estimated completion | 31 January 2022 |
Drugs / interventions tested
- ICBT for panic and depression
Conditions studied
- Panic Disorder — all drugs for Panic Disorder →
- Depression — all drugs for Depression →
Sponsor
Hebrew University of Jerusalem
Who can join
Adults 18 to 75, any sex, with Panic Disorder or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study examines uptake and attrition for internet based treatments for panic disorder and depression in Israel The primary benefits of this work will be a) in providing better understanding of ICBT for panic disorder and depression outcomes. Both panic and depression are heavy public health burdens, associated with a significant market potential for both therapeutic and diagnostic uses. b) In providing compatible scale to measure the working alliance during internet-based treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04659577
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Panic Disorder
Currently open trials in the same condition.
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07444879 — IL-33, sST2, and CRP in Panic Disorder · recruiting
- NCT07024758 — Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolesce · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
Other Hebrew University of Jerusalem trials
Trials by the same sponsor.
- NCT07003282 — A Study to Test Feasibility and Acceptability of an Intervention Program Aiming to Reduce Prenatal Secondhand Smoke Expo · NA · recruiting
- NCT05771545 — Telepsychiatry to Enable Expedited Disposition of Psychiatric Emergencies · active not recruiting
- NCT05447091 — Examining the Effectiveness of a Tablet Video Game on Mood and Cognition · NA · completed
- NCT04697316 — Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compar · NA · completed
- NCT07025603 — Evaluation of the Social ABCs in Israel · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04659577 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hebrew University of Jerusalem
- Last refreshed: 2 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04659577.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing